# Junta clínica — PT-pseudo_fdd4ff09679e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_fdd4ff09679e",
  "pid": "PT-pseudo_fdd4ff09679e",
  "task": 1,
  "psa": 4.4,
  "age": 62,
  "months": 1,
  "pirads": "5",
  "psad": 0.048,
  "psav": 0.75,
  "psap": 4.0,
  "vol": 91.11,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.78277797,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 4.4 ng/mL. PI-RADS 5. PSAD 0.05. Prostate volume 91 mL. csPCa 0.78.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "97 kg",
    "height": "180 cm",
    "bmi": "29.9",
    "bp": "133/72 mmHg",
    "hr": "70 bpm",
    "smoking": "Non-smoker",
    "last_dental": "6 mo ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "12 Jan 2025",
  "enc_ref": "Dr. H. Martens (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Assessment requested after previous prostate sampling and subsequent PSA elevation."
    },
    {
      "s": "History",
      "t": "At 62 years of age, this widowed gentleman entered evaluation in early 2023 due to an elevated PSA reading. Two subsequent biopsy procedures confirmed the prostate cancer diagnosis. He abstains from tobacco, consumes no alcohol, and manages moderate lower urinary tract symptoms, registering 13 points on the IPSS scale. Nocturia and acute urinary retention remain absent. A retired carpenter, he resides with his partner and dedicates weekends to hiking across nearby countryside. Cardiology evaluation in autumn 2024 indicated stable physiological parameters, while orthopaedic knee assessments reveal no functional restrictions. The patient historically favored adaptable clinic hours, though retirement has shifted that preference."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth; mobility: unremarkable; asymmetry: none. The examination confirms a normal DRE with a symmetrically enlarged prostate and firm capsule, lacking palpable nodules. Systemic assessment shows stable vital parameters. No lymphadenopathy or bone tenderness is evident."
    }
  ],
  "occupation": "retired carpenter",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Nephew",
  "recent_other": [
    "Orthopaedic outpatient — knee follow-up",
    "Cardiology — annual review (stable, autumn 2024)"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Hiking on weekends",
  "ipss": "IPSS score: 13/35 (moderate LUTS)",
  "admin": "Patient self-employed; flexible appointment slots requested.",
  "mri_hospital": "Amsterdam UMC (location AMC)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_fdd4ff09679e
Task: 1

Encounter: Urology - outpatient on 12 Jan 2025.
Referrer: Dr. H. Martens (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 62-year-old male
  - PSA: 4.4 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.048 ng/mL²
  - PSA velocity: 0.75 ng/mL/yr
  - Prior PSA: 4.0 ng/mL
  - Prostate volume: 91.11 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.78277797 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 4.4 ng/mL. PI-RADS 5. PSAD 0.05. Prostate volume 91 mL. csPCa 0.78.

Vitals: weight 97 kg, height 180 cm, BMI 29.9, BP 133/72 mmHg, HR 70 bpm. Smoking: Non-smoker.

Chief complaint: Assessment requested after previous prostate sampling and subsequent PSA elevation.

History: At 62 years of age, this widowed gentleman entered evaluation in early 2023 due to an elevated PSA reading. Two subsequent biopsy procedures confirmed the prostate cancer diagnosis. He abstains from tobacco, consumes no alcohol, and manages moderate lower urinary tract symptoms, registering 13 points on the IPSS scale. Nocturia and acute urinary retention remain absent. A retired carpenter, he resides with his partner and dedicates weekends to hiking across nearby countryside. Cardiology evaluation in autumn 2024 indicated stable physiological parameters, while orthopaedic knee assessments reveal no functional restrictions. The patient historically favored adaptable clinic hours, though retirement has shifted that preference.

Physical examination: DRE — texture: smooth; mobility: unremarkable; asymmetry: none. The examination confirms a normal DRE with a symmetrically enlarged prostate and firm capsule, lacking palpable nodules. Systemic assessment shows stable vital parameters. No lymphadenopathy or bone tenderness is evident.

Patient info: retired carpenter; Widowed; Lives with partner.
Next of kin: Nephew.

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Hiking on weekends; IPSS score: 13/35 (moderate LUTS).

Recent other appointments: Orthopaedic outpatient — knee follow-up; Cardiology — annual review (stable, autumn 2024).
Admin: Patient self-employed; flexible appointment slots requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.62
  uncertainty  +/- 0.11 epistemic (95% band 0.41-0.83); among patients I cannot tell apart the outcome was 0.96 of 1.00 mixed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 62 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 4.4 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 91.11 mL (1% of my signal; from log_vol, vol) · PSA density = 0.048 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.78 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 62 · DRE = Normal · PSA = 4.4 ng/mL · prostate volume = 91.11 mL · PSA density = 0.048 · PI-RADS = 5 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.75: PI-RADS 5, PSA 5.5, PSAD 0.12, age 71, DRE Normal -> BIOPSY (clear). He wrote: "Prev biopsy finding is left lobe, MRI finding highly suspicious of ISUP≥2 on right side. Active surveillance, only 1 biopsy session performed (of unclear date and unclea…"
  2. distance 1.76: PI-RADS 5, PSA 4.2, PSAD 0.06, age 67, DRE Nodus -> DEFER (uncertain). He wrote: "Need to know if the lesion has grown or if it is stabile."
  3. distance 1.78: PI-RADS 5, PSA 11.0, PSAD 0.108, age 70, DRE Normal -> BIOPSY (borderline). He wrote: "Patient on Activ Surveillance with severe LUTS symptoms. There are two options , recommend surgery direkt or do a new biopsy."

PRECEDENT: BIOPSY (weighted vote 0.67 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · PSA = 4.4 ng/mL
  noted      family history = not opened (0 of 91) · age = 62 · DRE = Normal · prostate volume = 91.11 mL · PSA density = 0.048 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 62 · PSA = 4.4 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 91.11 mL · PSA density = 0.048 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using PI-RADS thresholds to guide the decision to perform a biopsy. It states, "A PI-RADS threshold of $\\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline makes the PI-RADS threshold decisive, whereas EXPERT-STRUCTURED marked prior biopsy as decisive. The guideline suggests that the prior biopsy status is context, and the guideline requires the documented grade of the prior biopsy to settle the decision. The guideline requires the documented grade of the prior biopsy, which no panel variable represents.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on the documented grade of the prior biopsy, as the guideline suggests, and the information is located in the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Determine the trend of the serial PSA values.
  previous_notes (get_previous_notes) -> Determine the documented grade of the prior biopsy (Gleason or ISUP), the number and dates of biopsy sessions, whether he is on a surveillance protocol with a confirmatory biopsy due, and whether a TREATMENT is already agreed or declined.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Does the lesion in the radiology report show change compared to an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate MRI | Facility: Amsterdam UMC (AMC) | Date: 10 Jan 2025
COMPARISON: new
LESION: PI-RADS 5 lesion in the left peripheral zone measuring approximately 28 mm.

psa_trend
PSA 1.5 (May 2023), PSA 1.1 (Mar 2024), PSA 4.4 (Jan 2025)
psa_trend
PSA 1.5 (May 2023), PSA 1.1 (Mar 2024), PSA 4.4 (Jan 2025)

previous_notes
PRIOR GRADE: ISUP GG 2
BIOPSY SESSIONS: Two subsequent biopsy procedures confirmed the prostate cancer diagnosis.
SURVEILLANCE: Follow-up imaging and biopsy outcomes were slated for discussion during the subsequent appointment.
TREATMENT: none recorded

WHAT I DID NOT OPEN
family-history anamnesis, as it was not required to answer the open questions.

WHAT THIS SUPPORTS
FOR sampling this patient now
PRIOR GRADE: ISUP GG 2, as per EAU guideline, this grade suggests treatment rather than further tissue sampling.
psa_trend: The PSA trend shows a significant rise from 1.5 ng/mL in May 2023 to 4.4 ng/mL in Jan 2025.

AGAINST sampling this patient now
PRIOR GRADE: ISUP GG 2, which, according to the EAU guideline, suggests treatment rather than further tissue sampling.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.40 ng/mL over 3 points spanning 20 months; velocity +1.74 ng/mL per year; doubling time about 13 months.
PROJECTION at 6 months: 6.6 ng/mL, conformal 95% band 1.9-23.0.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 4.4 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.60
  uncertainty  +/- 0.10 epistemic (95% band 0.40-0.80), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 4.4 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 91.11 mL (4% of my signal; from log_vol, vol) · PSA density = 0.048 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.62  ('supports' tier; weight 2.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.60  ('discuss' tier, fusion_nolab; weight 1.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.67  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: GG 2 ("ISUP GG 2")

RULE THAT FIRED: documented prior grade GG 2 (ISUP GG 2) — carried by documented grade.
PANEL ANSWER: NO BIOPSY. A documented grade group of 2 or more is a treatment problem, not a sampling problem: the reading urologist deferred re-biopsy in 7 of the 8 labelled men with a recorded GG >= 2.
Dissenting on the board: EXPERT-STRUCTURED, EXPERT-FUSION, EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          62                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          4.4 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          91.11 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.048                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.78                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:DEC E2:—            -> important
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have answered the moderator's questions.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of NO BIOPSY, as the documented prior grade of ISUP GG 2 is the rule that fired.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? Answered by previous_notes: PRIOR GRADE: ISUP GG 2.
Q2. Does the lesion in the radiology report show change compared to an earlier study? Answered by radiology_report: COMPARISON: new.

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: Positive (decisive) because the documented prior grade ISUP GG 2 is the rule that fired in the PANEL-PROTOCOL, overriding other expert bids.
psa: important because the PSA trend shows a significant rise from 1.5 ng/mL in May 2023 to 4.4 ng/mL in Jan 2025, which supports the clinical context.
age: important because the patient is 62 years old, which is a variable noted by the panel.
MY SUGGESTION TO THE CHAIR
I suggest deferral, as the documented prior grade of ISUP GG 2, as retrieved by the registrar, is the decisive factor according to the PANEL-PROTOCOL.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: clear)

62y male, PSA 4.4, PI-RADS 5, prior biopsy ISUP GG 2. Prior diagnosis is established, so repeat biopsy is not indicated. The PI-RADS 5 finding is expected given the known cancer status and rising PSA. No earlier MRI to compare with.

What carried weight: bx=important, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
